INTRODUCTION
Proliferating cells have to replicate the DNA they will confer to their progeny. For the faithful transmission of the genetic information every base pair in the genome must be copied once and only once. To achieve this, eukaryotic cells rely on thousands of origins of replication distributed throughout the chromosomes that are fired in a tightly regulated manner once per mitotic division cycle. Origins of replication from different organisms conform to the replicon model (1) . According to this model, origins are defined by a specific DNA sequence, the replicator, and a protein or complex of proteins that recognizes the sequence and binds to it, the initiator. Upon firing, the initiator melts the DNA duplex in an ATP-dependent manner, allowing the loading of the DNA polymerase machinery. Additionally, the initiator may serve as an origin-specific tether for other proteins required in the replication such as the licensing factors that in eukaryotes mark unfired origins from those in already replicated regions.
The discovery of the first bona fide eukaryotic initiator, the Saccharomyces cerevisiae Origin Recognition Complex (ORC) (2) , and the subsequent identification of human, Caenorhabditis elegans, Arabidopsis thaliana, Schizosaccharomyces pombe (3) and Drosophila melanogaster homologs (4), represented a critical breakthrough to address crucial questions regarding the control of replication onset: How is replication initiation coupled to the cell cycle? Which is the ultimate signal that fires the origins of replication? How is the timing of firing determined for early and late origins? How is replication from each origin licensed so as to avoid re-replication? How does the cell sense completion of replication? Which sequences define metazoan replicators? Most of our current knowledge on eukaryotic initiation of replication is based on the budding yeast S. cerevisiae where ORC was first identified. However, understanding the specifics of replication in animal cells is crucial for comprehending the mechanisms underlying phenomena such as the change in usage of origins during development, or the gene amplification events that occur in normal and pathological states, as well as for designing future strategies for intervention. An intense effort has been devoted in recent years to the identification and characterization of metazoan Origin Recognition Complexes which we review in here. For recent reviews on the topic, please see Dutta and Bell (5) and Stillman (6).
THE SACCHAROMYCES CEREVISIAE ORIGIN RECOGNITION COMPLEX
The discovery that certain genomic sequences confer autonomous replication activity (ARS) to plasmids in the yeast (7) (8) (9) and that deletion of these sequences in the genome abolishes initiation of replication in that region (10-14) allowed the identification of the protein activity that binds to these putative origin sequences, the sixsubunit Origin Recognition Complex (2) . Experimental evidence supports that ORC is an eukaryotic initiator. Mutations in ARS that block the binding of ORC also abolish replication (2, 15, 16 ). The cloning of the genes for the different ORC subunits showed that all six are independently essential for viability. Conditional mutants in the genes result in arrest of yeast at the large-budded stage and subsequent entry into an abortive S phase. In addition, ORC mutants show decreased frequency of origin firing and an increased loss of ARS-containing plasmids (17-23). In the budding yeast, ORC is assembled as a stable complex bound to DNA throughout the cell cycle (24-27), indicating that additional factors must regulate origin firing. Several proteins have been identified that sequentially bind, thus assembling the so-called prereplicative complex (pre-RC) (see figure 1) . The unstable protein CDC6 binds to ORC upon exit from mitosis (25, 28, 29). The CDC6 gene was first identified in a screen for temperature sensitive mutants that were cell division cycle (CDC) defective (30). Binding of CDC6 to ORC is required for the subsequent incorporation of the MCM complex to the pre-RC (26, 31, 32). The six MCM2-7 (mini-chromosome maintenance) proteins were originally identified in screens for mutants that result in loss of plasmids bearing the yeast origin ARS or that were cell cycle defective (33, 34). The MCM complex is part of the eukaryotic licensing system that marks replicationcompetent chromatin (see this issue).
Regardless of the requirement of ORC, CDC6 and MCMs for initiation of replication, pre-RC genomic footprints are detected both in active and inactive origins in vivo (35), indicating that additional factors must determine which pre-RCs are competent for initiation. One candidate factor is CDC45. CDC45 is essential for DNA replication (36), and CDC45 protein incorporates to the origins at the G1 ->S transition, depending on CDC6, MCM and S-phase cyclin-cdk activity (37).
For the onset of replication S-phase cyclin-cdk and Dbf4-Cdc7 protein kinase activities are required (38-41) (and this issue). The same cyclin-cdk activity that drives cells into S phase also prevents re-assembly of preRCs at the origins, thus avoiding re-replication (40, 42) . Upon passage through mitosis, destruction of the mitotic cyclins by the APC and the proteasome results in termination of cdk activity, allowing pre-RCs to reassemble for a new round of replication.
METAZOAN ORCS

Complexes homologous to S. cerevisiae ORC in higher eukaryotes
Metazoan complexes formed by proteins homologous to the S. cerevisiae Origin Recognition Complex subunits have been identified in Drosophila and Xenopus. A stable complex containing homologs to yeast ORC1-6 can be isolated from Drosophila embryos by copurification with ORC2 (4, 43) . In Xenopus egg extracts a multiprotein complex containing homologs to ORC1-5 and other unidentified proteins has been isolated (44) (45) (46) (47) (48) . Also in the established somatic WAK Xenopus cell line, at least ORC1, 2 and 4 are associated as seen by coimmunoprecipitation with anti-ORC1 antibodies (48) .
Human and mouse homologs for ORC1 (3, 49) , ORC2 (3, 50) , ORC3 (48, 51) , ORC4 (48, 52) and ORC5 (48, 53, 54) have been cloned and characterized. In contrast to Drosophila and Xenopus, an endogenous complex containing all identified human ORC subunits has not been isolated.
Yet, co-immunoprecipitation experiments show that in human cells, endogenous ORC2 is associated with ORC4 (52) and with ORC3 (51) , and that ectopic ORC1 or ORC5 associate in vivo, with endogenous ORC2 (3) and ORC2-4 (51, 52, 54) respectively. Several reasons may account for the difficulty in isolating a human holocomplex. First ORC5 is poorly extracted under conditions that preserve protein-protein interactions, probably because ORC5 is associated with the nuclear matrix fraction (54) . Second, no association of endogenous ORC1 with other ORC subunits in asynchronous human cell cultures has yet been detected (54, 55) . It is possible that in human cells ORC1 assembles into ORC only in a limited window of time during the cell cycle. The cell cycle regulation of ORC1 in animal cells (see below) may account for the difficulty in seeing this subunit in an endogenous complex with other human ORC homologs in somatic cell extracts. The Drosophila and Xenopus holocomplexes containing ORC1 have been isolated from embryonic extracts, where large supplies of maternal proteins required for the rapid proliferation of early development are present. Third, although human ORC2 and ORC4 co-precipitate, several of the other proteins coprecipitating with each of them are different (52) . Although at least some of these proteins might be in a common complex that is dissociated during the experimental procedures, mammalian ORC might also have evolved into a more intricate system that will only be elucidated once all ORC interacting proteins are identified. One indicator of a higher degree of complexity in mammalian cells is an alternatively spliced form of ORC5, ORC5T, which has been identified and is expressed in human cells (54) . The role of ORC5T is not yet known, although it interacts in vivo with ORC4 but not with ORC2 under conditions where ORC5 interacts with both. One such subunit might play a regulatory role in replication. Alternatively ORC5T may represent a separation of functions in higher eukaryotes and be involved in functions aside from the onset of S phase. It is worth noting that ORC5 has been suggested to play a still undefined role in mitosis in S. cerevisiae (56) , and that Drosophila ORC is involved in heterochromatin formation (43) (see section 7).
ORC subunits and CDC6 belong to a super-family of proteins that bind and hydrolyze NTPs
In addition to ORC subunits, Xenopus (57) and human (55, 58, 59) homologs for the budding yeast CDC6 have been identified. Metazoan CDC6 is essential for initiation of replication (see below).
Protein sequence comparison reveals that CDC6, ORC1, ORC4 and ORC5 share extensive sequence similarity (21, 48, 52, 58, 60) . Similarities include highly conserved Walker A and B motifs. These sequences are present in numerous DNA binding proteins that exhibit duplex unwinding or helicase activity, where they function as purine nucleotide binding and hydrolysis domains respectively (61) . The function of the Walker A and B motifs in the different metazoan ORC subunits has not been investigated. In S. cerevisiae, ORC binds ATP and this binding is stimulated by, and required for, ORC binding to ARS DNA (62) . The subunit responsible for this activity is ORC1. ORC1 mutants in the Walker A and B motifs are unable to complement a deletion in the ORC1 gene (21, 62) . ORC5 has only a Walker A motif, and its role is less clear. Yeasts with mutations in theWalker A motif of ORC5 are viable (22) and complexes with mutant ORC5 can bind to ARS (62) , but the mutation reduces ORC function in vivo (22). Interestingly, two different human clones for ORC5 have been reported whose single sequence difference is a mutation in the Walker A motif that would suppress ATP binding (54) . The finding that hypomorphic ORC mutants may result in maldevelopment of specific brain structures in Drosophila (see 5.1) opens the intriguing possibility that the observed genetic polymorphism of ORC5 in humans may be of functional relevance.
Sequence homology extends beyond the proteins mentioned above to include both prokaryotic and eukaryotic proteins of the "clamp-loader" family and unknown archaebacterial proteins (48, 60) . "Clamploaders" like RF-C or the E. coli gamma complex utilize the energy of hydrolysis of ATP to load ring-shaped sliding clamps (PCNA, beta complex) on to DNA. Therefore, the eukaryotic ORC subunits might be the result of an evolutionary specialization from a common ancestor with the "clamp-loader" family of proteins. The archebacterial proteins homologous to ORC/CDC6 proteins, probably belong to the same family of proteins and are either similarly involved in the initiation of DNA replication (like CDC6, ORC) or in the loading of a processivity factor for DNA polymerase (like RF-C).
FUNCTION OF METAZOAN ORC
Metazoan ORC is essential for initiation of replication
Metazoan ORC, like its S. cerevisiae counterpart, is essential for replication. In Drosophila, ORC2 is encoded by the k43 gene (63) first identified as a late-larval lethal null mutant (64, 65) . Notably, the defects leading to death are limited to structures that depend on continued diploid cell division after maternal supplies of protein are depleted in late larval stages, with larvae characteristically showing small or missing imaginal discs (66, 67) . k43 null mutants also show diploid cells with reduced mitotic index and fragmented chromosomes (66, 67 ). An ORC2 mutant, k43 fs293 , has been identified that specifically results in suppression of gene amplification while diploid cell chromosome replication is not affected (63, 68) . The mutants develop into viable adults but females are sterile due to underproduction of the chorion proteins required for the egg shell. The k43 fs293 mutation may selectively affect gene amplification by two mechanisms. Chorion gene amplification relies essentially on a single origin (69, 70) . Because the frequency of origin firing is decreased to half in the k43 fs293 hypomorphic mutation (63), one observes a more profound defect in amplification of regions with a single origin of replication than in chromosomal replication, where a moving fork may extend from neighboring origins. Alternatively the k43 fs293 mutation disrupts a domain in Drosophila ORC2 essential for interaction of an amplification-specific factor. This would make this mutant a useful tool to identify the factors that determine gene amplification during oogenesis, and possibly in the identification of analogous functions involved in gene amplification in human cancer.
Similar results showing that ORC is essential for replication have been obtained for Latheo, the Drosophila ORC3 homolog. Flies carrying null mutations in Latheo arrest replication completely after second instar larvae, as shown by BrdU incorporation and the arrested development of the CNS. The time of the arrest correlates with depletion of the maternal supplies of proteins that support cell division through embryonic and larval stages. Null mutants die in early pupal stage lacking imaginal discs (51) . Latheo was originally identified in a behavioral screen for olfactory memory mutants in fruit flies (71) . The original lat P1 mutant with impaired learning capacity is a mild hypomorphic mutation that affects anatomical structures of the adult brain. Homozygous lat P1 mutants develop normally with the exception of a significant reduction in the volume of the mushroom bodies, a brain structure involved in olfactory memory. The number of neurons in the mushroom bodies depends most critically on continued proliferation of mid-brain neuroblasts for an extended period of time during development (51) . The hypomorphic mutation in Latheo/ORC3 might specifically affect the size of this adult tissue compartment, perhaps because the replication machinery is most stressed in these specific neuroblasts on account of their prolonged proliferation window. Alternatively, reduction in ORC activity might decrease (but not abolish) origin firing. As a result the chromosomes are replicated from fewer origins resulting in a subtle elongation of S phase. This slight prolongation of the cell cycle might have no effect on most tissue compartments whose size is measured during development by the number of cell divisions. However, in certain tissue compartments, inhibitory influences from neighbors might arrive after a specific time of development. In those compartments alone the number of cells is expected to diminish when the cell cycle is slightly prolonged. Whether polymorphisms in this or other ORC subunits exist in humans that may result in similar developmental deficits is an intriguing question. Interestingly, a human ORC5 clone has been identified with a mutation that removes the ATP binding Walker A motif (54), a mutation that in yeast results in reduced ORC function in vivo (22).
ORC is also essential for the initiation of replication in Xenopus egg extracts. Immunodepletion of ORC1, ORC2 or ORC3 from the extracts completely abolishes in vitro replication initiation of sperm DNA, but not elongation of replication on single-stranded DNA templates (44) (45) (46) (47) . Replication can be rescued in ORCdepleted extracts by addition of MCM-depleted extracts which by themselves are also unable to support replication (46) . Similar immunodepletion experiments demonstrate that CDC6 is also essential for initiation in egg extracts (57) . Additional support for ORC being the initiator in animal cells comes from the observation that ORC1 from egg extracts binds to demembranated sperm DNA to a saturation limit of one molecule every 16 kb (45) , close to the observed 10-20 kb replicon size in early embryos (72) (73) (74) .
Finally, in Xenopus cells in culture, ORC immunostaining partially overlaps with sites of DNA replication during early, but not later, time-points in S phase (46) .
No direct proof of involvement of ORC in initiation of replication has been demonstrated in mammalian cells. In vivo immunodepletion of CDC6 by microinjection of specific antibodies into human cell nuclei prevents entry into S phase, indicative of an essential role for at least this protein in the initiation of replication in mammals (59, 75).
ORC binding to chromatin
Does ORC remain bound to chromatin throughout the cell cycle in animal cells as in budding yeast? One would expect ORC binding to chromatin to be a more dynamic process in animal cells, where origin usage changes upon the transition from embryonic to somatic cell cycles, or upon methylation or transcription status, or upon change from endoreduplication to gene amplification in oogenesis. Most experimental evidence suggests indeed that metazoan ORC does not remain permanently bound to the chromatin throughout the entire cell cycle. At least during oogenesis in Drosophila follicle cells, a dramatic change in the ORC nuclear localization occurs when cells reach stage 10B of ovarian development and switch from endoreduplication cycles of the entire genome to amplification of specific genes. Both ORC1 and ORC2 change from a diffuse nuclear immunolocalization to discrete foci coincident with the loci of gene amplification, according to two independent groups (76, 77) . Furthermore, at stage 11 of ovarian development, when replication ceases in follicle cells, ORC2 is no longer detectable (77) . Other lines of evidence also support that metazoan ORC is not permanently bound to the chromatin. During Drosophila development ORC1 protein is not immunodetected in non-proliferating tissues (76), although as discussed below the presence of this subunit seems to be distinctive of proliferating cells, and therefore its absence does not necessarily reflect the absence of other ORC subunits. In Xenopus egg extracts and cells in culture, ORC remains bound to chromatin during S phase, but later the association seems to cease according to biochemical and microscopic studies (45, 46, 57) . In human cells, the cell cycle variations of an in vivo footprint in the putative origin at the Lamin B2 locus have been convincingly described (78) . The footprint enlarges along G1 phase, in a way compatible with the assembly of a pre-RC, shrinks during S phase, and remains unaltered through G2 phase until it disappears completely at M phase. However, it has not been demonstrated that ORC is responsible for this footprint. Presence of ORC bound to chromatin in G2 phase receives circumstancial support from the observation that permeabilized HeLa G2 nuclei are able to replicate in ORC-depleted Xenopus extracts, but not in MCM-depleted extracts (46) .
On the other hand, ORC has been reported to remain bound to chromatin through the entire cell cycle in different Drosophila tissues, and loss of nuclear signal during mitosis was suggested to be due to an experimental artifact (43) . While the question remains open, a structural role of ORC in the formation of heterochromatin (43) does not in itself eliminate the possibility of ORC ever leaving the chromatin in M phase. The structural requirement for ORC binding could be limited to a specific time during the cycle of proliferating cells and may not be necessary in M phase. One mechanism has been described on how localization of ORC may be regulated. The change in ORC distribution that occurs in the switch from chromosomal endoreduplication to gene amplification requires the transcription factor E2F (77). As described above, during ovarian development in Drosophila follicle cells undergo several rounds of endoreduplication, with diffuse nuclear ORC staining, and then enter a phase of gene amplification at four specific foci, with ORC localizing to these foci solely. Mutants in E2F or DP with an intact transactivation domain and an inactive DNA binding domain, abolish the focal localization of ORC. An E2F mutant with a deletion in the pRb binding and transactivation domain but an intact DNA binding domain still allows the relocalization of ORC to amplification foci, and results in earlier amplification. This observation indicates that the DNA binding domain of E2F but not the transcription activation domain is involved in assisting chromatin binding of ORC, either directly by physically interacting with ORC, or indirectly by changing the chromatin structure adjoining the E2F binding site.
ORC recruits other factors to the origins
In Xenopus egg extracts, loading of CDC6 to the pre-replicative complexes requires ORC (57), and CDC6 is in turn required for the loading of the MCM complex onto chromatin (45, 46, 57) , whereas the loading of ORC needs neither CDC6 nor MCM protein (46) , pointing to a sequential assembly of the components of the preRCs. Similarly, in quiescent human cells ORC2 is bound to the chromatin and MCM5 is present in a soluble nuclear fraction but unable to bind to chromatin when cells are induced to enter the cell cycle. Once CDC6 protein is expressed in G1, MCM5 can now bind to the chromatin. Therefore ORC appears to facilitate the loading of CDC6 which promotes the loading of MCM protein (79) . There is no direct evidence about which ORC subunits are involved in recruiting other proteins to the origins. However, in S. cerevisiae, the electrophoretic mobility of ORC6 changes prior to CDC6 loading and changes back at the time CDC6 is lost from the chromatin (80) . S. cerevisiae ORC6 is dispensable for in vitro DNA binding (81) but essential for DNA replication, suggesting the role of ORC6 in the complex may be to recruit CDC6 and other proteins to the origin.
Competence to initiate DNA replication in a mammalian in vitro system coincides with the time of maximum CDC6 accumulation and maximum binding of the MCM complex to the chromatin. At this point, entry into S phase can be accelerated just by recombinant CycE/cdk2 (see below). This licensing can be accelerated by adding recombinant Xenopus CDC6 to permeabilized G1 phase nuclei (79) . However, during a specific time interval after release from quiescence, nuclei fail to respond to exogenous CDC6 (79) . At this time endogenous CDC6 is already present and bound to the chromatin but MCMs remain soluble, indicating the presence of a negative factor, or the absence of a positive factor that regulates MCM binding. A Xenopus protein, geminin, inhibits DNA replication by preventing the incorporation of MCM complex onto chromatin (82) . Geminin accumulates during S, G2, and M phases, and disappears at the time of the metaphase-anaphase transition, and could be the hypothetical negative factor that regulates MCM binding.
It is uncertain whether in the normal cell cycle CDC6 remains bound to the chromatin (57) or is released upon loading of the MCM complex (83) in Xenopus egg extracts. Once the binding of MCMs to the chromatin has taken place, however, replication can proceed independent of chromatin-bound ORC and CDC6, although it still depends on cdk2 (83) . Whether at this point the origin DNA duplex is already unwound and stabilized by RPA, MCMs or other proteins is not known. Indeed, a weak but significant helicase activity has been identified in a subcomplex of human MCMs in vitro (84).
REGULATION OF METAZOAN ORC
Regulation of ORC expression
The mRNA expression of human and Drosophila ORC1 (76, 85) and human CDC6 (55, 59, 75, 86) is cell cycle regulated with the human CDC6 promoter responding to the E2F transcription factor. This dependence links initiation of replication with the pRb-E2F cell cycle control pathway, and ensures that when quiescent cells are stimulated to enter the cell cycle, ORC1 and CDC6 are both synthesized at the G1/S transition and are available for origin function.
The regulation of metazoan ORC1 by E2F confers an additional level of control of initiation of replication to animal cells as compared to S. cerevisiae, where the six-subunit ORC is bound to chromatin throughout the cell cycle (2, 24) and only CDC6 is regulated (87, 88) . In fruit flies the abundance of ORC1 protein varies during development and the cell cycle, accumulating in proliferating cells in late G1 and S (76) . Additional evidence indicates that the level of ORC1 protein determines origin utilization (76) . Expression of ectopic ORC1 during Drosophila development alters the proliferation program. Proliferation is detected in tissues where no proliferation is expected under normal conditions, and it correlates with the presence of ORC1 protein.
Ectopic ORC1 results in general DNA replication in follicle cells in stage 10B of ovarian development where otherwise replication is restricted to four foci undergoing gene amplification. It will be interesting to learn how ectopic ORC1 drives quiescent cells into replication overcoming the need of limiting factors like CDC6 (Drosophila CDC6 has not been reported yet, although it is reasonable to assume that a homolog for this gene, which is present in yeasts, Xenopus and mammals, exists in fruit flies) or Sphase cyclin-cdk activity.
Overexpression of exogenous ORC1 or CDC6 in mammalian cells does not result in the same effect as described above for Drosophila, whereas overexpression of E2F in starved fibroblasts does drive cells into S phase without the addition of serum (86) . Although levels of ectopic ORC1 or CDC6 may not have reached a critical threshold, these results may indicate that the expression of additional genes regulated by E2F may be limiting for replication initiation in mammalian cells. In any case, mRNA expression of ORC1 and CDC6, but not other ORC subunits, correlate with proliferation in human tissues (54, 75) , indicating that ORC1 and CDC6 may be limiting factors in determining which chromatin-bound ORC complexes are competent for pre-RC formation. Given the dependency of ORC1 and CDC6 expression on E2F and the fact that deregulation of the pRb/E2F pathway is a common trait in many human malignancies (89, 90) , anomalous activation of E2F may induce expression of ORC1 and CDC6 and promote the driving of cells from quiescence into proliferation.
In contrast to the restricted expression of ORC1 and CDC6 to proliferating cells, expression of mammalian ORC2-5 is not cell cycle regulated (52, 54, 55) . The mRNA of these subunits are detected in tissues that do not proliferate significantly such as spleen and ovary (49, 50, 54) , suggesting that ORC may be involved in additional functions besides initiation of replication (see section 7).
CDC6 availability is regulated by changes in subcellular localization
In contrast to the regulation in mRNA expression, human ORC1 and CDC6 protein levels do not fluctuate in whole cell extracts throughout the cell cycle (55) , indicating that the protein is not totally degraded at the G1/S transition as is CDC6 in yeasts (87, 88, (91) (92) (93) . Instead, control of the availability of CDC6 appears to be exerted by regulation of subcellular localization, with the protein localized in nuclei during G1 and in cytoplasm upon onset of S phase (55) . Also in Xenopus egg extracts CDC6 is not degraded in S phase but appears to move from the chromatin to the nuclear envelope (57) .
The observed cell cycle dependent changes in subcellular localization of CDC6 in human cells might be explained either by destruction of nuclear CDC6 and cytoplasmic accumulation of newly synthesized protein, or by the relocalization of the protein within the cell. Several lines of evidence give support to the latter (94) (95) (96) . Overexpression of exogenous cyclin A leads to rapid cytoplasmic localization of CDC6. Ectopic CDC6 protein in which two N-terminal cdk phosphorylation consensus sites (that are phosphorylated in vivo) have been removed remains always nuclear. A mutant with acidic residues instead of the cdk substrate serines to mimick the negative charge associated with phosphorylation remains cytoplasmic.
Phosphorylation of CDC6 by cyclin A-cdk2 at the onset of S phase and the subsequent removal of the protein from the nucleus suggest a mechanism that could prevent re-replication. However, overexpression of nonphosphorylatable CDC6 mutants which localize to the nucleus is not sufficient to induce re-replication (94) (95) (96) in the way it does in fission yeast (97), indicating that additional mechanisms preventing re-replication are active in animal cells. A protein, geminin, has been identified in Xenopus that accumulates from S to M phase and inhibits the loading of MCM onto the chromatin (82), and could be involved in preventing re-replication.
Origin firing
The ultimate signals and targets responsible for origin firing have not been demonstrated. In budding yeast, both S-phase cyclin-cdk and Dbf4-Cdc7 protein kinase activities are required for the onset and progress of replication. In human cells, once MCMs are loaded onto the chromatin, cyclin E-cdk2 in a buffered solution is enough to initiate replication in G1 nuclei in vitro (79) . The efficiency of replication initiation is equivalent to that induced by S-phase cytosolic extracts, indicating that the targets activated are likely the same in both cases. This requirement of cyclin E couples origin firing to the pRb/E2F cell cycle control pathway at still another level (see above, regulation). Neither cyclin A-cdk2 nor cyclin B-cdc2 are able to support initiation in the same in vitro experiment (79) . In fact cyclin B-cdc2 inhibits initiation, consistent with its role in mitosis and the need that initiation is repressed to avoid re-replication after a round of semi-conservative replication is finished and cells exit S phase. However, cyclin A-cdk2 has been localized to replication foci (98) , suggesting it may play a regulatory role.
Human CDC6 can bind to (55, 94) and be phosphorylated by cycA-cdk2 in vivo, triggering its subcellular relocalization from nucleus to cytoplasm (94) . In agreement with the above mentioned observations, this phosphorylation does not seem to be the signal that fires the origins, since ectopic non-phosphorylatable mutants do not act as dominant negative mutants that block the onset of Sphase, although it is not known whether they are otherwise functional (94) (95) (96) . It has been proposed that the role of this phosphorylation is more likely to avoid re-assembly of pre-RC on already-fired origins by subcellular relocalization of the protein as described in 5.2.
Xenopus ORC1 and 2, but not 4 are hyperphosphorylated in M-phase (metaphase) extracts with respect to interphase extracts (44, 47, 48) . Although the significance of this phosphorylation is unknown, the timing is compatible with a potential release of ORC from the chromatin (45, 46, 57, 83) .
Human ORC1 is phosphorylated in vitro by human cyclin A-cdk2 and to a lesser extent by human cyclin B-cdc2 (49).
ORC BEYOND REPLICATION
The pattern of tissue specific ORC expression in mammals reveals a surprising result (49, 50, 54) . In addition to the expected expression in proliferating tissues like testis or colon mucosa, ORC subunits are also expressed in variable levels in tissues without significant proliferation, like spleen, ovary or prostate. These observations support the involvement of ORC in functions independent of cell proliferation.
One such possible function has been identified in Drosophila, implicating ORC in formation of silencingrelated heterochromatin (43) . This result is compatible with the involvement of yeast ORC in transcription silencing (17, 18, 20, 22, 99) . Early observation showed abnormal chromosome condensation in Drosophila k43 mutants (67) . The k43 gene encodes Drosophila ORC2 (63) . In fruit flies, ORC colocalizes and interacts with HP1, a structural component of heterochromatin. HP1 lacks DNA binding activity, and ORC2 mutants disrupt the localization of HP1 to the heterochromatin (100), indicating that the role of ORC in heterochromatin formation in animal cells resembles that played by yeast ORC in telomeric and cryptic mating loci silencing, as a DNAbound tether for the proteins responsible for the assembly of the silenced chromatin. Interestingly, flies heterozygous for ORC2 (+/-) show suppression of position effect variegation, indicating that the requirement for ORC in chromatin structure is dosage-dependent. The implications of this finding are ample. For instance a copy of the ORC5 gene is found consistently deleted in some tumors (54) . It is possible that as seen in Drosophila, hemizygosity results in haploinsufficiency and reduced silencing, allowing an increased expression of oncogenes and growth factors. The observation that uterine leiomyomas with the chromosomal deletion that includes ORC5 grow slower in culture than leiomyomas with other chromosomal aberrations supports the idea that loss of one copy of the gene may result in haploinsufficiency.
Possibly also related to a structural role for ORC in chromatin, S. cerevisiae ORC5 has been shown to be required in early M phase in addition to G1/S (56), although the exact role in mitosis is currently unknown. On a similar note, the fly ORC3 protein ( latheo) is expressed in the adult brain, and the protein is detected in the cytoplasm in the synaptic vesicles, where it has been proposed plays a role in neuronal plasticity (101).
PERSPECTIVE
If ORC is the initiator in animal cells, it is expected to bind to replicator sequences. Despite substantial effort replicators in higher eukaryotes have remained elusive to date.
With metazoan Origin Recognition Complexes finally at hand, it may be anticipated that the identity of the long-sought metazoan replicators will be soon uncovered.
How ORC binding to DNA is influenced by chromatin structure will help understand how origins are modified according to development and transcription activity in higher eukaryotes. A dramatic change in origin usage occurs for instance during Xenopus development after the mid-blastula transition (102) , coincident with the commencement of gene transcription and subsequent changes in chromosome structure. Also accessory factors affect origin localization and usage. Accessory factors like transcription factors in the origins may help by bending the DNA so as to facilitate duplex unwinding or ORC binding or accessibility of the preRC to other replication factors. An interesting observation is that the binding of c-myc near the c-myc human origin of replication facilitates replication initiation at the origins (103) . The potential involvement of E2F in directing ORC to specific loci (77) may be another example of this phenomenon.
How many pieces of the puzzle are still missing remains to be seen. So far, human cells seem to cope with at least an alternatively spliced form of ORC5, ORC5T, whose function is not known yet (54) . The ultimate targets that are activated at initiation of replication awaits further elucidation. Which elements of the pre-RC are actually required for the firing? Is ORC dispensable in animal cells once CDC6 and MCM are loaded? Even if ORC is dispensable for origin firing in the Xenopus egg extract in vitro system (83), we cannot rule out that ORC is required in vivo even after the loading of MCM protein. The possible roles of ORC in chromatin structure related to silenced heterochromatin suggest a role in the condensation of mitotic chromosomes. Yeast ORC may be one target of the checkpoint kinase Rad53 that slows the rate of replication in response to DNA damage (104) . A similar mechanism might be active in mammals, where CHO cells respond to ionizing radiation by inhibiting initiation (at the DHFR locus) rather than inhibiting elongation (105, 106) . Although this checkpoint mechanism has been detected by using DNA-damaging agents, under normal conditions mutation of Rad53 results in the early firing of normally late S phase origins, indicating that Rad53 also delays the timing of initiation from late origins during normal yeast cell growth (104, 107, 108) As though a role as the eukaryotic initiator was not important enough, it is exciting to see the influence of ORC extending well beyond the (replication) origins. Involvement in the formation of silenced-state heterochromatin, consistent reduction to hemizygosity in tumors, and potential involvement in learning defects are some of the ramifications that already extend the role of the metazoan Origin Recognition Complex.
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